Omega Funds is a Venture Capital based in Boston.

How many investments has Omega Funds made?

Omega Funds has made 76 disclosed investments.

How much does Omega Funds manage?

Omega Funds manages $2.5B in assets.

What does Omega Funds invest in?

Omega Funds invests in Life Sciences Early Stage, Seed, Late Stage companies.

Omega Funds

Q: What companies has Omega Funds invested in?

Omega Funds's portfolio includes Callio Therapeutics, BioSilta, Arpida, NRG Therapeutics, Newron, Juno Therapeutics.

Venture Capital

Leading international investment firm that creates and invests in life sciences companies targeting the worlds most urgent medical needs.

Boston, United States · 76+ investments · 133 portfolio companies

Website

Early Stage

Seed

Late Stage

Life Sciences

Headquarters: Boston, United States
Founded: 2004
Website: omegafunds.com
AUM: $2.5B

Portfolio Companies: 133
Total Investments: 76
Last Investment: Feb 2026
Geographic Focus: United States, Europe

Investment Thesis

We invest in exceptional people and impactful products. Bringing science to patients by investing in the future of medicine across oncology, immunology, rare diseases, precision medicine and others.

Omega Funds is a Venture Capital firm based in Boston, United States. It has made 76 investments in Life Sciences, including Callio Therapeutics, BioSilta and Arpida.